IRIS
BERTONI, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.076
AS - Asia 6.806
EU - Europa 5.955
SA - Sud America 835
AF - Africa 387
Continente sconosciuto - Info sul continente non disponibili 187
OC - Oceania 6
Totale 25.252
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.777
SG - Singapore 2.356
CN - Cina 2.014
IT - Italia 1.109
VN - Vietnam 1.043
FI - Finlandia 975
SE - Svezia 812
IE - Irlanda 804
BR - Brasile 662
DE - Germania 596
UA - Ucraina 464
HK - Hong Kong 452
FR - Francia 246
ZA - Sudafrica 243
NL - Olanda 241
GB - Regno Unito 237
BD - Bangladesh 228
TR - Turchia 193
CA - Canada 186
IN - India 140
RU - Federazione Russa 113
BE - Belgio 75
AR - Argentina 67
CI - Costa d'Avorio 65
ES - Italia 60
MX - Messico 51
AT - Austria 49
JP - Giappone 45
CZ - Repubblica Ceca 42
TH - Thailandia 39
IQ - Iraq 35
PH - Filippine 35
KR - Corea 34
PK - Pakistan 33
PL - Polonia 31
ID - Indonesia 28
EC - Ecuador 24
CO - Colombia 21
RO - Romania 20
EU - Europa 17
MA - Marocco 17
VE - Venezuela 17
TW - Taiwan 16
LT - Lituania 15
EG - Egitto 14
JM - Giamaica 13
MY - Malesia 13
PY - Paraguay 12
UZ - Uzbekistan 11
CL - Cile 10
ET - Etiopia 10
KE - Kenya 10
PA - Panama 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
HU - Ungheria 9
IR - Iran 9
AZ - Azerbaigian 8
CR - Costa Rica 8
NP - Nepal 8
PT - Portogallo 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
JO - Giordania 7
LB - Libano 7
HN - Honduras 6
PE - Perù 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
BY - Bielorussia 5
DZ - Algeria 5
HR - Croazia 5
KZ - Kazakistan 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
DK - Danimarca 4
IL - Israele 4
MD - Moldavia 4
NI - Nicaragua 4
OM - Oman 4
QA - Qatar 4
SC - Seychelles 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
CH - Svizzera 3
EE - Estonia 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AO - Angola 2
BN - Brunei Darussalam 2
CM - Camerun 2
LY - Libia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SV - El Salvador 2
Totale 25.064
Salva come PNG Salva come JPEG
Città #
Dallas 2.939
Singapore 1.281
Ashburn 965
Dublin 803
Chandler 790
San Jose 761
Santa Clara 529
Jacksonville 495
Beijing 476
Hong Kong 418
Ann Arbor 383
Dearborn 376
Ho Chi Minh City 322
Parma 314
Boardman 292
Council Bluffs 251
Johannesburg 231
New York 226
Hanoi 212
Nanjing 187
Munich 176
Los Angeles 169
Shanghai 158
Izmir 154
Princeton 138
Lauterbourg 137
Wilmington 107
Hefei 91
San Mateo 90
Toronto 87
Helsinki 84
Buffalo 73
São Paulo 68
Abidjan 65
Brussels 65
Hebei 64
Nanchang 62
Kunming 60
Bremen 55
Guangzhou 55
Jinan 54
Moscow 54
Shenyang 50
Chicago 49
Frankfurt am Main 49
Milan 49
Haiphong 48
Woodbridge 44
Changsha 43
Bologna 42
London 40
Seattle 40
Da Nang 39
Montreal 39
Vienna 38
Des Moines 37
Tokyo 34
Groningen 33
Tianjin 33
Columbus 30
Turku 30
Marseille 28
Bangalore 27
Brooklyn 27
Grafing 27
Amsterdam 26
Rome 26
Reggio Emilia 25
Auburn Hills 24
Fremont 24
Norwalk 24
Orem 24
Brno 23
Houston 23
Rio de Janeiro 23
Warsaw 23
Atlanta 21
Hangzhou 21
Jiaxing 21
Denver 20
Zhengzhou 20
Manchester 18
Modena 18
Curitiba 17
Hải Dương 17
Mexico City 17
Nuremberg 17
Stockholm 17
Bangkok 16
Chennai 16
Belo Horizonte 15
Boston 15
Brescia 15
Jakarta 15
Madrid 15
Ottawa 15
Pune 15
Dhaka 14
Naples 14
Phoenix 14
Totale 15.861
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.719
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 1.649
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 255
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 254
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 244
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 235
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 230
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 226
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 223
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 220
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 212
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 209
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses 202
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 199
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 199
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 199
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 197
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 195
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 193
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 187
Multi-Target CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach 186
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 185
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 182
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 182
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 181
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 181
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 179
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 179
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 178
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 177
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 174
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 174
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 172
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 172
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 172
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 171
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 170
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 169
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 168
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 167
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 167
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 165
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 164
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 163
Analgesic activity of new hybrid muscarinic agonists in mice 163
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 162
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 162
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 162
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 160
Motor responses of rat hypertrophic intestine following chronic obstruction 160
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 160
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 160
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 160
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 158
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 157
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 156
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 155
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 154
Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats 154
Benzofuran-2-Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20-Induced Chemotaxis and Colon Cancer Growth 153
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 153
PHARMACOLOGICAL CHARACTERIZATION OF NEW COMPOUNDS AIMED AT INHIBITING EPH-EPHRIN INTERACTION IN GLIOBLASTOMA 152
Influence of Nitric Oxide system in mesenteric ischemia-reperfusion induced injury in mice 151
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 151
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 149
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 148
CNS access of selected H3-antagonists: ex vivo binding study in rats 147
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 147
Influence of gender in the mesenteric ischemia/reperfusion model in mice 145
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 144
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 144
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 144
Heterogeneous response of colonoid-derived monolayers to TNFa and IFNg exposure: functional and morphological characterization 143
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 143
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 143
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 143
The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice 142
Different role of the Histamine H3 Receptor in Vagal-, Betanechol-, Pentagastrin-induced Gastric Acid Secretion in Anaesthetized Rats 140
Up-regulation of inhibitory transmitters in myenteric neurons of the rat ileum in an acute model of ischemia/reperfusion 140
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 140
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 138
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 136
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 136
RESPONSIVENESS OF LONGITUDINAL AND CIRCULAR MUSCLE TO RELAXING MEDIATORS IS DIFFERENTIALLY AFFECTED IN RAT HYPERTROPHIED ILEUM 135
Evidence for the involvement of 5-HT(2A) receptors in mild mesenteric ischemia/reperfusion dysfunctions in mice 133
Role of Glutamate- N-methyl-D-Aspartate (NMDA) Receptors in Neuronal Plasticity and Gastrointestinal Transit Delay Induced by Ischemia/Reperfusion in Rats 133
Synthesis and pharmacological screening of novel non-acidic gastric-sparing antiinflammatory/antiplatelet agents:5-alkyl/cycloalkylamino substituted 2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines 133
Protection by the EPH-EPHRIN System Against Mesenteric Ischemia-Reperfusion Injury 133
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies 130
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 130
Synthesis and Biological Evaluation of N-Pyrazolyl-N'-alkyl/benzyl/phenylureas: a New Class of Potent Inhibitors of Interleukin 8-Induced Neutrophil Chemotaxis 129
Involvement of 5-HT2A receptors in motor and inflammatory disorders induced by mesenteric ischemia reperfusion in mice 128
Screening di nuovi agenti antiinfiammatori/antiaggreganti non-acidici: sviluppo di 2-amino-5H-[1]benzopirano[4,3-d]pirimidine 5-alchil/cicloalchilamino sostituite prive di attivita' gastrolesiva 128
Effects of CCL20/CCR6 modulators in a T cell adoptive transfer model of colitis 127
Allosteric Modulation of Muscarinic Acetylcholine-Receptors: Oxotremorine-Phthalimidoalkyl-Hybrids of the Hexamethonio-type 126
Synthesis and functional characterization of novel heterocyclic derivatives related to oxotremorine and oxotremorine-M 126
PHENYLPROPANOID RICH ESSENTIAL OILS AS POTENTIAL ANTITHROMBOTICS ENDOWED WITH GASTROPROTECTIVE EFFECTS 125
Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions 124
New analogues of oxotremorine and oxotremorine-M: estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes 124
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 124
Totale 19.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.356
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022804 0 23 32 91 51 56 94 104 33 58 58 204
2022/20233.138 347 320 181 234 320 344 67 174 932 45 121 53
2023/20241.227 69 80 46 47 88 313 126 84 38 66 97 173
2024/20253.732 137 193 260 237 383 430 157 168 398 367 271 731
2025/202610.802 842 1.238 2.826 796 1.127 476 871 282 1.144 650 333 217
2026/2027497 207 290 0 0 0 0 0 0 0 0 0 0
Totale 25.252